Trimodal Therapy for MIBC Offers Favorable Response Rates - Renal and Urology News
Nearly 59% of patients with cT2-T3 urothelial carcinoma were disease-free at the time of last follow-up. A growing body of evidence supporting trimodal therapy as a viable alternative to radical cystectomy for bladder cancer.
New York United States Priya Dave Society Of Urologic Oncology Albert Einstein College Of Medicine Montefiore Medical Center
Source: renalandurologynews.com